EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte Studie

Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery

Mohamed Izzad Isahak iD, Muhammad Safwan Abdullah iD, Raflis Ruzairee Awang, Nor Faezan Abdul Rashid, Seniyah Md Sikin, Shahrun Niza Abdullah Suhaimi iD, Norlia Abdullah, Rohaizak Muhammad, Nani Harlina Md Latar

World Journal of Surgery · 2024

DOI: 10.1002/wjs.12134 ↗

At a glance

Randomisierte kontrollierte Studie in World Journal of Surgery, 2024. Written by Mohamed Izzad Isahak and 8 co-authors. Institution: Department of Surgery, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia. Major MEDLINE topics: Seroma, Lymph Node Excision, Breast Neoplasms, Axilla. Cited 3 times so far (Crossref); 21 references. Funded by: Jet Pharma.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Axillary lymph node dissection (ALND) in breast cancer management, necessitates a nuanced understanding of complications that may impede treatment progression. This study scrutinize the impact of Haemoblock hemostatic solution, evaluation it's potential in reducing seroma complication by controlling lymph flow and obliterating axillary dead space.

Method

A prospective, randomized, double‐blinded controlled trial was conducted with 58 patients undergoing breast conserving surgery (BCS) and ALND, stratified into two groups: Group A (ALND + Haemoblock, n = 29) and Group B (ALND + placebo, n = 29). Postoperative drainage charts were monitored, with the primary endpoint being the time to drain removal, Additionally, patients were observed for surgical site infection (SSI).

Results

Group A exhibited a marginally higher mean total drain output (398 +/− 205 vs. 326 +/− 198) compared to Group B, this difference did not attain statistical significance ( p = 0.176). Equally, the mean time to drain removal demonstrated no discernible distinction between the two groups (6 +/− 3.0 vs. 6 +/− 3.0, Group A vs. Group B, p = 0.526). During follow up, nine patients in Group A required seroma aspiration (mean aspiration 31 +/− 73) as compared to Group B, 6 patients required aspiration (mean aspiration 12 +/− 36), p = 0.222). No notable disparity in SSI rates between the groups was identified.

Conclusion

In conclusion, the administration of Haemoblock did not manifest a discernible effect in mitigating seroma production, hastening drain removal, or influencing SSI rates following ALND. The study underscores the intricate and multifactorial nature of seroma formation, suggesting avenues for future research to explore combined interventions and protracted follow‐up periods for a more comprehensive understanding.

Subjects

MeSH terms (MEDLINE)

SeromaLymph Node ExcisionBreast NeoplasmsAxillaMastectomy, SegmentalHemostaticsHumansFemaleMiddle AgedProspective StudiesDouble-Blind MethodAgedDrainageAdultTreatment OutcomeSurgical Wound InfectionPostoperative Complications

Author keywords

breasteducationoncologyoutcomes

Substances

Hemostatics

Authors and institutions

  • Department of Surgery, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia.
  • Breast and Endocrine Unit, Department of Surgery, Hospital Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Kuala Lumpur, Malaysia.
  • Breast and Endocrine Unit, Department of Surgery, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia.
  • Breast and Endocrine Unit, Department of Surgery, Hospital Sultan Ismail, Johor Bahru, Malaysia.
  • Breast and Endocrine Unit, Department of Surgery, Hospital Canselor Tuanku Muhriz UKM, Cheras, Kuala Lumpur, Malaysia.

ORCID profiles: Mohamed Izzad Isahak, Muhammad Safwan Abdullah, Shahrun Niza Abdullah Suhaimi

Funding

  • Jet Pharma

Cite

APA

Isahak, M. I., Abdullah, M. S., Awang, R. R., Abdul Rashid, N. F., Md Sikin, S., Abdullah Suhaimi, S. N., Abdullah, N., Muhammad, R., & Md Latar, N. H. (2024). Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery. World Journal of Surgery. https://doi.org/10.1002/wjs.12134

Vancouver

Isahak MI, Abdullah MS, Awang RR, Abdul Rashid NF, Md Sikin S, Abdullah Suhaimi SN, et al. Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery. World Journal of Surgery. 2024. doi:10.1002/wjs.12134

BibTeX
@article{Isahak2024,
  author = {Isahak, Mohamed Izzad and Abdullah, Muhammad Safwan and Awang, Raflis Ruzairee and Abdul Rashid, Nor Faezan and Md Sikin, Seniyah and Abdullah Suhaimi, Shahrun Niza and Abdullah, Norlia and Muhammad, Rohaizak and Md Latar, Nani Harlina},
  title = {Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery},
  journal = {World Journal of Surgery},
  year = {2024},
  doi = {10.1002/wjs.12134}
}
Start for free →